Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Patients”

542 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 542 results

Not applicableStudy completedNCT05236296
What this trial is testing

Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study

Who this might be right for
Leukemia, Acute
University Health Network, Toronto 40
Early research (Phase 1)Looking for participantsNCT06225856
What this trial is testing

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorHematological Malignancy
Shanghai Yuyao Biotech Co., Ltd. 96
Not applicableStudy completedNCT07150286
What this trial is testing

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

Who this might be right for
Immune Thrombocytopenic PurpuraHELICOBACTER PYLORI INFECTIONS
Al-Mustansiriyah University 100
Testing effectiveness (Phase 2)Ended earlyNCT03718533
What this trial is testing

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

Who this might be right for
Poor Graft Function
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT05549232
What this trial is testing

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

Who this might be right for
Hematologic NeoplasmsBurns
Hemanext 22
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableNot Yet RecruitingNCT07525024
What this trial is testing

KSD-101 in Patients With EBV-associated Hematological Malignancies

Who this might be right for
EBV Associated Lymphoid Neoplasms
Ruijin Hospital 80
Early research (Phase 1)Study completedNCT02143635
What this trial is testing

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Who this might be right for
Advanced Solid and Hematological TP53wt Tumors
Novartis Pharmaceuticals 208
Early research (Phase 1)Study completedNCT00904787
What this trial is testing

Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Relapsed or Refractory Hematological Malignancies
CASI Pharmaceuticals, Inc. 27
Testing effectiveness (Phase 2)UnknownNCT02828878
What this trial is testing

Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
Cellect Biotechnology 12
Early research (Phase 1)Looking for participantsNCT06950034
What this trial is testing

STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia (CMML)Chronic Myelomonocytic Leukemia-1+9 more
Solu Therapeutics, Inc 105
Testing effectiveness (Phase 2)Study completedNCT00843947
What this trial is testing

Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan

Who this might be right for
Hematologic Malignancies
University of California, Davis 8
Testing effectiveness (Phase 2)Study completedNCT02483325
What this trial is testing

Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases

Who this might be right for
Hematological Diseases
Institut Paoli-Calmettes 33
Not applicableStudy completedNCT03079089
What this trial is testing

Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

Who this might be right for
Refractory or Relapsed Lymphoid Haemopathy
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175415
What this trial is testing

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory+2 more
Princess Maxima Center for Pediatric Oncology
Not applicableNot Yet RecruitingNCT07541326
What this trial is testing

Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 85
Testing effectiveness (Phase 2)WithdrawnNCT04392128
What this trial is testing

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Who this might be right for
COVID19Hematologic Malignancy
Institut de cancérologie Strasbourg Europe
Not applicableLooking for participantsNCT03890614
What this trial is testing

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

Who this might be right for
Hematologic Malignancy
Wake Forest University Health Sciences 70
Not applicableStudy completedNCT04745416
What this trial is testing

Clinical Characteristics of Patients With Leukemia and COVID-19

Who this might be right for
Leukemia, AcuteCovid19Leukemia, Lymphoblastic
Hospital General de Mexico 30
Large-scale testing (Phase 3)Study completedNCT00382759
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Elderly

Who this might be right for
Hematological Malignancies
Azienda Ospedaliera San Giovanni Battista 50
Load More Results
42